• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Hu-manity.co Acquires Betterpath Health Empowering Patients with Access to Healthcare’s Dark Data

Share:

May 6, 2019

Hu-manity.co, the company bringing individuals and corporations into a consumer-inclusive data economy, announced the acquisition of Betterpath; a four-year-old Brooklyn, New York company with unique technologies that works on behalf of patients to search, find, and improve healthcare data that is currently difficult to access. The combined organization creates a powerful combination of Consumer Consent as a Service, and healthcare’s untapped datasets. Patients empowered with consent via Hu-manity.co’s #My31 app for Apple and Android will be able to request deep clinical datasets from hospitals, clinics, and laboratories which are often still on paper, behind
fax machines, unstructured and referred to by Andreessen Horowitz’s general partner Vijay Pande, as healthcare’s “Dark Data”.

Matt Sinderbrand, CEO and co-founder of Betterpath will join Hu-manity.co as Senior Vice President, Chief Product Officer as well as a member of the Hu-manity.co Board of Directors. “The track and trace of consent and
authorization model that Hu-manity.co has brought to market has been what is missing in healthcare data from the inception,” states Sinderbrand. “The simple idea that we should put the consumer (the patient) into the center of
the healthcare data supply chain with ownership rights literally at their fingertips is both powerful, and timely.”

Sinderbrand started Betterpath after experiencing first-hand his sister’s struggle with accessing her own healthcare data while battling Crohn’s disease, and as a result prioritized the training of Betterpath’s Lumos medical natural language understanding to learn more than 100,000 biomedical-terms, synonyms, relationships, and structured codes. In honor of his sister’s condition, the first disease vocabulary programmed was Inflammatory Bowel Disease.

“I’ve seen and evaluated technology for two decades. The Betterpath architecture, stack, and scalability is one of the best I have seen to date in healthcare data retrieval,” says Richie Etwaru, CEO of Hu-manity.co. “Matt is a first-class citizen in the new cohort of healthcare data experts; he has learned more over the past four years while getting the technology ready than most of the healthcare venture community combined.” The Betterpath technology core includes Amazon Web Services, React, Datomic, Docker, Cassandra, and Scala wrapped by fax automation, real time APIs, trained Optical Character Recognition, the NPI database, the Unified Medical Language System, and a patented process of medical natural language training and understanding.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

With this acquisition Hu-manity.co adds two patents to its intellectual property portfolio and now operates an IRB approved observational research cohort that enables healthcare’s dark data to be used for FDA regulated clinical trials powering the discovery of transformational medicine.

Date: May 06, 2019

Source: Bloomberg

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • CATO SMS Acquires Array BiostatisticsCATO SMS Acquires Array Biostatistics
  • Olive Lands $51M to Power AI-powered Digital Employee PlatformOlive Lands $51M to Power AI-powered Digital Employee Platform
  • StageBio Expands Its Global Presence with Acquisition of TPL Path LabsStageBio Expands Its Global Presence with Acquisition of TPL Path Labs
  • Oregon House Passes Telemedicine Reimbursement Bill to Promote Safe Access to CareOregon House Passes Telemedicine Reimbursement Bill to Promote Safe Access to Care
  • DrChrono EHR Adds Live Chat, PDMP, Inline Charting, Vital Flowsheet FeaturesDrChrono EHR Adds Live Chat, PDMP, Inline Charting, Vital Flowsheet Features
  • Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. Ii Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination
  • Truepill Launches End-to-End COVID-19 Virtual Care PlatformTruepill Launches End-to-End COVID-19 Virtual Care Platform
  • Enzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)Enzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications